Changes of Serum Ficolin-3 and C5b-9 in Patients with Heart Failure

Hongli Li1, Fangfang Zhang2, Dan Zhang3

  • 1Hongli Li, Department of Cardiology, Baoding First Central Hospital, Baoding, Hebei 071000, China.

Insights

Serum ficolin-3 levels decrease with worsening heart failure, while C5b-9 levels increase. These markers, ficolin-3 and C5b-9, do not correlate with the cause of heart failure.

Area of Science:

  • Cardiology
  • Immunology
  • Biochemistry

Background:

  • Heart failure (HF) is a complex clinical syndrome with significant morbidity and mortality.
  • Biomarkers are crucial for assessing cardiac function and disease severity in HF patients.
  • Ficolin-3 and the terminal complement complex C5b-9 are implicated in inflammatory processes.

Purpose of the Study:

  • To investigate the correlation between serum ficolin-3 and C5b-9 levels and cardiac function, as indicated by NT-proBNP, in heart failure patients.
  • To assess the relationship of these markers with the severity of heart failure.
  • To determine if ficolin-3 and C5b-9 levels are associated with the etiology of heart failure.

Main Methods:

  • Sixty heart failure patients (NYHA class II-IV) were enrolled and compared to 20 healthy controls.
  • Serum levels of ficolin-3, C5b-9, and NT-proBNP were measured.
  • Correlation analyses were performed between these markers and heart failure severity and etiology.

Main Results:

  • Serum concentrations of ficolin-3 and C5b-9 were significantly different between heart failure patients and controls.
  • Ficolin-3 showed a negative correlation with NT-proBNP (r=-0.606, p<0.0001), indicating inverse association with heart failure severity.
  • C5b-9 demonstrated a positive correlation with NT-proBNP (r=0.499, p<0.0001), suggesting direct association with heart failure severity.

Conclusions:

  • Serum ficolin-3 is inversely associated with heart failure severity.
  • Serum C5b-9 is positively associated with the severity of cardiac impairment in heart failure.
  • Neither ficolin-3 nor C5b-9 levels showed a significant association with the underlying etiology of heart failure.
Abstract

Related Concept Videos

Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
82
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
252
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
96
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
72
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
173
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.0K